Legato Capital Management LLC Eye Point Pharmaceuticals, Inc. Transaction History
Legato Capital Management LLC
- $761 Million
- Q3 2024
A detailed history of Legato Capital Management LLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Legato Capital Management LLC holds 48,780 shares of EYPT stock, worth $511,702. This represents 0.05% of its overall portfolio holdings.
Number of Shares
48,780
Previous 19,437
150.96%
Holding current value
$511,702
Previous $169,000
130.18%
% of portfolio
0.05%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding EYPT
# of Institutions
150Shares Held
58MCall Options Held
177KPut Options Held
263K-
Cormorant Asset Management, LP Boston, MA8.33MShares$87.3 Million4.66% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.18MShares$54.3 Million1.63% of portfolio
-
Franklin Resources Inc San Mateo, CA4.01MShares$42.1 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.79MShares$39.8 Million0.06% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$39.5 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $357M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...